Cellectis
CLLS
27 hedge funds and large institutions have $16.9M invested in Cellectis in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 5 closing their positions.
1.17% more ownership
Funds ownership: 17.7% → 18.87% (+1.2%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less funds holding
Funds holding: 29 → 27 (-2)
25% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 8
27% less capital invested
Capital invested by funds: $23M → $16.9M (-$6.1M)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS AM
Chicago,
Illinois
|
+$4.87M |
| 2 |
BGI
B Group Inc
Dallas,
Texas
|
+$259K |
| 3 |
LFCM
Long Focus Capital Management
San Juan,
Puerto Rico
|
+$148K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$39.2K |
| 5 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$37.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
-$3.33M |
| 2 |
Millennium Management
New York
|
-$638K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$274K |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$224K |
| 5 |
Morgan Stanley
New York
|
-$166K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PS
26
Principal Securities
Des Moines,
Iowa
| $94 | – | – | – |
|
|
EWA
27
EverSource Wealth Advisors
Birmingham,
Alabama
| $16 | – | – | – |
|
|
28
Capital International Investors
Los Angeles,
California
| – | -$3.33M | -1,848,804 | Closed |
|
29
Citadel Advisors
Miami,
Florida
| – | -$62.6K | -34,786 | Closed |
|
30
Two Sigma Investments
New York
| – | -$49.2K | -27,322 | Closed |
|
|
XT
31
XTX Topco
George Town,
Cayman Islands
| – | -$18.9K | -10,526 | Closed |
|
32
Osaic Holdings
Scottsdale,
Arizona
| – | -$546 | -303 | Closed |
|
CLLS Hedge Fund Activity: Q1 2025 in Review
27 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q1 2025, worth a combined $16.9M — down 27% from $23M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of CLLS and 3 opened new positions — a net loss of 2 holders — while 8 trimmed existing stakes and 6 added.
The largest buyer was UBS AM, adding an estimated $4.87M. The largest seller was Capital International Investors, exiting entirely with an estimated $3.33M sold.
- 27 institutional investors held Cellectis (CLLS) as of Q1 2025, down from 29 in Q4 2024.
- Funds reported $16.9M of Cellectis stock for Q1 2025, down 27% quarter-over-quarter.
- 3 funds opened new Cellectis positions in Q1 2025 and 5 closed out, a net change of -2 holders.
- The largest Cellectis buyer in Q1 2025 was UBS AM, an estimated $4.87M added.
- The largest Cellectis seller in Q1 2025 was Capital International Investors, an estimated $3.33M sold.
Based on aggregated 13F filings for Q1 2025.